BlueRock Therapeutics to Present at Cowen and Company 39th Annual Health Care Conference

Tuesday, March 5, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

CAMBRIDGE, Mass., March 5, 2019 /PRNewswire/ -- BlueRock Therapeutics, LP, an engineered cell therapy company leveraging

its novel Cell+Gene platform to develop regenerative medicines for intractable diseases, today announced that Emile Nuwaysir, Ph.D., Chief Executive Officer of BlueRock Therapeutics, will present at the Cowen and
Company 39th Annual Health Care Conference on Tuesday, March 12, 2019, at 4:30 p.m. ET at the Boston Marriott Copley Place.

About BlueRock Therapeutics BlueRock Therapeutics is an engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock's Cell+Gene platform harnesses the power of cells for new medicines across neurology, cardiology and autoimmune indications. BlueRock's cell differentiation technology recapitulates the cell's developmental biology to produce native cell therapies which are further engineered for additional function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. BlueRock was founded in 2016 by Versant Ventures and capitalized with one of the largest-ever Series A financings in biotech history by Bayer AG and Versant. BlueRock's culture is defined by scientific innovation, highest ethical standards and an urgency to bring transformative treatments to all who would benefit. For more information, visit www.bluerocktx.com.

Investors:Candice Ellis, 978-879-7273Associate Director, Investor Relations and Corporate Communications cellis@bluerocktx.com

Media Contacts: David Schull or Maggie Beller Russo Partners, LLC (646) 942-5631 Maggie.beller@russopartnersllc.com

Cision View original content:http://www.prnewswire.com/news-releases/bluerock-therapeutics-to-present-at-cowen-and-company-39th-annual-health-care-conference-300806258.html

SOURCE BlueRock Therapeutics



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store